Price
No data yet.
Social Signal Score
Analyst Ratings
5 analystsRevenue
$5.96M+23740.00%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Maria Degois Sainz
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 102
- Beta
- 1.50
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -7.84
Financials
Revenue
$5.96M+23740.0%Net Income
$-5.98MEBITDA
$-5.43MFree Cash Flow
$-6.10MEPS (diluted)
$-0.06Shares Outstanding (diluted)
106.11M+2194.5%Operating Expenses
$10.64MCash & Debt
$37.87MRevenue by Segment (annual)
$13.56MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $13.56M | $-35.57M | $-0.43 |
| 2024 | $12.89M | $-40.72M | $-0.56 |
| 2023 | $11.03M | $-44.24M | $-0.62 |
| 2022 | $6.81M | $-73.16M | $-1.04 |
| 2021 | $1.50M | $-64.83M | $-0.92 |
| 2020 | $294.0K | $-23.36M | $-0.93 |
| 2019 | $0.00 | $-18.79M | $-4.06 |
Valuation
HYPRhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
30-76.92%Social Signal Score
Mentions (5)
- Newsbusinesswire.com·3d ago·Negative
Hyperfine to Present at the Piper Sandler 38th Annual Healthcare Conference on December 3 GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that management will present at the Piper Sandler 38th Annual Healthcare Conference in New York on Thursday, December 3, 2026 at 9:10 a.m. Eastern Time. Managem…
View source ↗ - Newsseekingalpha.com·12d ago·Positive
Hyperfine, Inc. (HYPR) Q3 2026 Earnings Call Transcript Hyperfine, Inc. (HYPR) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·13d ago·Negative
What Hyperfine (HYPR) Said on Its Q3 Earnings Call Hyperfine NASDAQ: HYPR reported record third-quarter revenue and gross margin, while narrowing its operating loss and reducing cash burn as sales of its portable brain MRI system increased across its U.S. and international markets.
View source ↗ - Newsbusinesswire.com·45d ago·Negative
… Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the third quarter ended September 30, 2026. “Our preliminary t…
View source ↗ - Newsbusinesswire.com·45d ago·Negative
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026 GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the third quarter 2026 on Monday, November 9, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacif…
View source ↗
Earnings
Wed, Mar 17(in 4 months)
Consensus estimate $-0.07 per share
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 9$-0.07 vs $-0.08beat
- Thu, Aug 6$-0.09 vs $-0.09beat
- Tue, May 12$-0.09 vs $-0.09beat
- Wed, Mar 18$-0.08 vs $-0.08beat
- Thu, Nov 13$-0.11 vs $-0.10miss
- Wed, Aug 13$-0.12 vs $-0.12beat
Estimates and results for HYPR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HYPR officers and directors.
- Bought
- $1.7m
- Sold
- $236k
14 trades
25 trades
- Teisseyre Thomassold
- Hale Brettsold
- Hale Brettsold
- Teisseyre Thomassold
- Teisseyre Thomassold
- Hale Brettsold
- Teisseyre Thomassold
- Teisseyre Thomassold
61 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in HYPR.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
